Role of inflammatory mediators in the pathogenesis of epilepsy

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Shimada, Tadayuki ^a   Takemiya, Takako ^b   Sugiura, Hiroko ^a   Yamagata, Kanato ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROSTAGLANDIN; ANTICONVULSIVE AGENT;

DISEASE EXACERBATION; EPILEPSY; EPILEPTOGENESIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PATHOGENESIS; REVIEW; SEIZURE; SEIZURE THRESHOLD; ENCEPHALITIS; IMMUNOLOGY; METABOLISM;

ANTICONVULSANTS; CYTOKINES; ENCEPHALITIS; EPILEPSY; HUMANS;

EID: 84907247075     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/901902     Document Type: Review

References (79)

1. Devinsky O., Effects of seizures on autonomic and cardiovascular function. Epilepsy Currents 2004 4 2 43 46
2. Pellock J. M., Understanding co-morbidities affecting children with epilepsy. Neurology 2004 62 5, supplement 2 S17 S23 10.1212/WNL.62.11.17A 2-s2.0-1542346293
3. Jones J. E., Austin J. K., Caplan R., Dunn D., Plioplys S., Salpekar J. A., Psychiatric disorders in children and adolescents who have epilepsy. Pediatrics in Review 2008 29 2 e9 e14 10.1542/pir.29-2-e9 2-s2.0-38849145182
4. Wetherington J., Serrano G., Dingledine R., Astrocytes in the epileptic brain. Neuron 2008 58 2 168 178 10.1016/j.neuron.2008.04.002 2-s2.0-42149112453
5. Friedman A., Kaufer D., Heinemann U., Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Research 2009 85 2-3 142 149 10.1016/j.eplepsyres.2009.03.005 2-s2.0-67650465533
6. Greenwood J., Etienne-Manneville S., Adamson P., Couraud P., Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascular Pharmacology 2002 38 6 315 322 10.1016/S1537-1891(02)00199-4 2-s2.0-0036627483
7. MacDonald R. L., Rogawski M. A., Cellular effects of antiepileptic drugs. Epilepsy: A Comprehensive Textbook 2008 2nd Wolters Kluwer/Lippincott Williams & Wilkins 1433 1445
8. Haghikia A., Ladage K., Hinkerohe D., Vollmar P., Heupel K., Dermietzel R., Faustmann P. M., Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. Journal of Neuroscience Research 2008 86 8 1781 1788 10.1002/jnr.21639 2-s2.0-45549094173
9. Matoth I., Pinto F., Sicsic C., Brenner T., Inhibitory effect of carbamazepine on inflammatory mediators produced by stimulated glial cells. Neuroscience Research 2000 38 2 209 212 10.1016/S0168-0102(00)00127-9 2-s2.0-0033805322
10. Viviani B., Gardoni F., Marinovich M., Cytokines and Neuronal Ion Channels in Health and Disease. International Review of Neurobiology 2007 82 247 263 10.1016/S0074-7742(07)82013-7 2-s2.0-34547279579
11. Vezzani A., French J., Bartfai T., Baram T. Z., The role of inflammation in epilepsy. Nature Reviews Neurology 2011 7 1 31 40 10.1038/nrneurol.2010.178 2-s2.0-78651369895
12. Itoh K., Watanabe M., Yoshikawa K., Kanaho Y., Berliner L. J., Fujii H., Magnetic resonance and biochemical studies during pentylenetetrazole- kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures. Neuroscience 2004 129 3 757 766 10.1016/j.neuroscience.2004.09.025 2-s2.0-8444229703
13. Vigevano F., Cilio M. R., Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 1997 38 12 1270 1274 10.1111/j.1528-1157.1997.tb00063.x 2-s2.0-0031468870
14. Shumiloff N. A., Lam W. M., Manasco K. B., Adrenocorticotropic hormone for the treatment of West syndrome in children. Annals of Pharmacotherapy 2013 47 5 744 754 10.1345/aph.1R535 2-s2.0-84877097431
15. Crow A. R., Song S., Semple J. W., Freedman J., Lazarus A. H., A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 2007 109 1 155 158 10.1182/blood-2006-05-023796 2-s2.0-33845976292
16. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A., Worley P. F., Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993 11 2 371 386 10.1016/0896-6273(93)90192-T 2-s2.0-0027290813
17. Maroso M., Balosso S., Ravizza T., Iori V., Wright C. I., French J., Vezzani A., Interleukin-1 β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011 8 2 304 315 10.1007/s13311-011-0039-z 2-s2.0-79955053045
18. Minami M., Kuraishi Y., Satoh M., Effects of kainic acid on messenger RNA levels of IL-1 β IL-6, TNF α and LIF in the rat brain. Biochemical and Biophysical Research Communications 1991 176 2 593 598 10.1016/S0006-291X(05)80225-6 2-s2.0-0025844833
19. Eriksson C., Tehranian R., Iverfeldt K., Winblad B., Schultzberg M., Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration. Journal of Neuroscience Research 2000 60 2 266 279
20. de Simoni M. G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., de Luigi A., Garattini S., Vezzani A., Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. European Journal of Neuroscience 2000 12 7 2623 2633 10.1046/j.1460-9568.2000.00140.x 2-s2.0-0033943296
21. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M. G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T., Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proceedings of the National Academy of Sciences of the United States of America 2000 97 21 11534 11539 2-s2.0-12944273495
22. Turrin N. P., Rivest S., Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiology of Disease 2004 16 2 321 334 10.1016/j.nbd.2004.03.010 2-s2.0-2942555126
23. Voutsinos-Porche B., Koning E., Kaplan H., Ferrandon A., Guenounou M., Nehlig A., Motte J., Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiology of Disease 2004 17 3 385 402 10.1016/j.nbd.2004.07.023 2-s2.0-9644289382
24. Gorter J. A., van Vliet E. A., Aronica E., Breit T., Rauwerda H., Lopes da Silva F. H., Wadman W. J., Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. Journal of Neuroscience 2006 26 43 11083 11110 10.1523/JNEUROSCI.2766-06.2006 2-s2.0-33751099302
25. Jung K. H., Chu K., Lee S. T., Kim J., Sinn D. I., Park D., Lee J., Kim S. U., Kim M., Lee S. K., Roh J., Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiology of Disease 2006 23 2 237 246 10.1016/j.nbd.2006.02.016 2-s2.0-33746263652
26. Yoshikawa K., Kita Y., Kishimoto K., Shimizu T., Profiling of eicosanoid production in the rat hippocampus during kainic acid-induced seizure: dual phase regulation and differential involvement of COX-1 and COX-2. The Journal of Biological Chemistry 2006 281 21 14663 14669 10.1074/jbc.M511089200 2-s2.0-33744955628
27. Aronica E., Gorter J. A., Gene expression profile in temporal lobe epilepsy. Neuroscientist 2007 13 2 100 108 10.1177/1073858406295832 2-s2.0-34047140937
28. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., Lallement G., Dorandeu F., Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007 238 2-3 166 176 10.1016/j.tox.2007.05.032 2-s2.0-34547770719
29. Lee B., Dziema H., Lee K. H., Choi Y., Obrietan K., CRE-mediated transcription and COX-2 expression in the pilocarpine model of status epilepticus. Neurobiology of Disease 2007 25 1 80 91 10.1016/j.nbd.2006.08.015 2-s2.0-33751169109
30. Kulkarni S. K., Dhir A., Cyclooxygenase in epilepsy: from perception to application. Drugs of Today 2009 45 2 135 154 10.1358/dot.2009.45.2.1322481 2-s2.0-66249132320
31. Holtman L., van Vliet E. A., Edelbroek P. M., Aronica E., Gorter J. A., Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Research 2010 91 1 49 56 10.1016/j.eplepsyres.2010.06.011 2-s2.0-77956010858
32. Polascheck N., Bankstahl M., Löscher W., The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Experimental Neurology 2010 224 1 219 233 10.1016/j.expneurol.2010.03.014 2-s2.0-77953707753
33. Auvin S., Shin D., Mazarati A., Sankar R., Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010 51 supplement 3 34 38 10.1111/j.1528-1167.2010.02606.x 2-s2.0-77954525284
34. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A. M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A. A., Bianchi M. E., Vezzani A., Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature Medicine 2010 16 4 413 419 10.1038/nm.2127 2-s2.0-77950539231
35. Campbell I. L., Abraham C. R., Masliah E., Kemper P., Inglis J. D., Oldstone M. B. A., Mucke L., Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proceedings of the National Academy of Sciences of the United States of America 1993 90 21 10061 10065 10.1073/pnas.90.21.10061 2-s2.0-0027433102
36. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G., TNF- α transgenic and knockout models of CNS inflammation and degeneration. Journal of Neuroimmunology 1997 72 2 137 141 10.1016/S0165-5728(96)00184-1 2-s2.0-0031054933
37. Vezzani A., Granata T., Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005 46 11 1724 1743 10.1111/j.1528-1167.2005.00298.x 2-s2.0-33644625777
38. Kuno K., Matsushima K., The IL-1 receptor signaling pathway. Journal of Leukocyte Biology 1994 56 5 542 547 2-s2.0-0028143674
39. Park J. S., Gamboni-Robertson F., He Q., Svetkauskaite D., Kim J. Y., Strassheim D., Sohn J. W., Yamada S., Maruyama I., Banerjee A., Ishizaka A., Abraham E., High mobility group box 1 protein interacts with multiple Toll-like receptors. The American Journal of Physiology-Cell Physiology 2006 290 3 C917 C924 10.1152/ajpcell.00401.2005 2-s2.0-33645461206
40. Rodgers K. M., Hutchinson M. R., Northcutt A., Maier S. F., Watkins L. R., Barth D. S., The cortical innate immune response increases local neuronal excitability leading to seizures. Brain 2009 132 9 2478 2486 10.1093/brain/awp177 2-s2.0-71549171171
41. Wang S., Cheng Q., Malik S., Yang J., Interleukin-1 β inhibits γ -aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. The Journal of Pharmacology and Experimental Therapeutics 2000 292 2 497 504 2-s2.0-0033621660
42. Schäfers M., Sorkin L., Effect of cytokines on neuronal excitability. Neuroscience Letters 2008 437 3 188 193 10.1016/j.neulet.2008.03.052 2-s2.0-43049154803
43. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M. M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C. L., Marinovich M., Interleukin-1 β enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. Journal of Neuroscience 2003 23 25 8692 8700 2-s2.0-0141535180
44. Vezzani A., Maroso M., Balosso S., Sanchez M., Bartfai T., IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain, Behavior, and Immunity 2011 25 7 1281 1289 10.1016/j.bbi.2011.03.018 2-s2.0-79955681780
45. Renno T., Krakowski M., Piccirillo C., Lin J.-., Owens T., TNF- α expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis: Regulation by Th1 cytokines. Journal of Immunology 1995 154 2 944 953 2-s2.0-0028983573
46. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., Volterra A., CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity. Nature Neuroscience 2001 4 7 702 710 10.1038/89490 2-s2.0-0034960228
47. Ravizza T., Gagliardi B., Noé F., Boer K., Aronica E., Vezzani A., Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiology of Disease 2008 29 1 142 160 10.1016/j.nbd.2007.08.012 2-s2.0-36549071601
48. Morin-Brureau M., Lebrun A., Rousset M., Fagni L., Bockaert J., de Bock F., Lerner-Natoli M., Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. The Journal of Neuroscience 2011 31 29 10677 10688 10.1523/JNEUROSCI.5692-10.2011 2-s2.0-79960669855
49. Librizzi L., Noè F., Vezzani A., de Curtis M., Ravizza T., Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Annals of Neurology 2012 72 1 82 90 10.1002/ana.23567 2-s2.0-84863728498
50. Heinemann U., Kaufer D., Friedman A., Blood-brain barrier dysfunction, TGF β signaling, and astrocyte dysfunction in epilepsy. GLIA 2012 60 8 1251 1257 10.1002/glia.22311 2-s2.0-84862321002
51. Ransohoff R. M., Kivisäkk P., Kidd G., Three or more routes for leukocyte migration into the central nervous system. Nature Reviews Immunology 2003 3 7 569 581 10.1038/nri1130 2-s2.0-0142259710
52. Rantala H., Tarkka R., Uhari M., Systematic review of the role of prostaglandins and their synthetase inhibitors with respect to febrile seizures. Epilepsy Research 2001 46 3 251 257 10.1016/S0920-1211(01)00281-9 2-s2.0-0034881231
53. Marcheselli V. L., Bazan N. G., Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus: inhibition by a platelet-activating factor antagonist. The Journal of Biological Chemistry 1996 271 40 24794 24799 10.1074/jbc.271.40.24794 2-s2.0-0029748545
54. Takemiya T., Matsumura K., Yamagata K., Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochemistry International 2007 51 2-4 112 120 10.1016/j.neuint.2007.05.009 2-s2.0-34547492807
55. 2produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region. Neuroscience Research 2006 56 1 103 110 10.1016/j.neures.2006.06.003 2-s2.0-33747883648
56. Kunz T., Oliw E. H., Nimesulide aggravates kainic acid-induced seizures in the rat. Pharmacology and Toxicology 2001 88 5 271 276 10.1034/j.1600-0773.2001.d01-116.x 2-s2.0-0035017762
57. Baik E. J., Kim E. J., Lee S. H., Moon C., Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Research 1999 843 1-2 118 129 10.1016/S0006-8993(99)01797-7 2-s2.0-0007414682
58. Serrano G. E., Lelutiu N., Rojas A., Cochi S., Shaw R., Makinson C. D., Wang D., Fitzgerald G. A., Dingledine R., Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. Journal of Neuroscience 2011 31 42 14850 14860 10.1523/JNEUROSCI.3922-11.2011 2-s2.0-80054741188
59. 2is crucial for seizure suppression and postictal sleep. Experimental Neurology 2014 253 82 90 10.1016/j.expneurol.2013.12.002
60. Chung J. I., Kim A. Y., Lee S. H., Baik E. J., Seizure susceptibility in immature brain due to lack of COX-2-induced PGF2α Experimental Neurology 2013 249 95 103 10.1016/j.expneurol.2013.08.014
61. Jiang J., Quan Y., Ganesh T., Pouliot W. A., Dudek F. E., Dingledine R., Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation. Proceedings of the National Academy of Sciences of the United States of America 2013 110 9 3591 3596 10.1073/pnas.1218498110 2-s2.0-84874483489
62. Jiang J., Ganesh T., Du Y., Quan Y., Serrano G., Qui M., Speigel I., Rojas A., Lelutiu N., Dingledine R., Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2. Proceedings of the National Academy of Sciences of the United States of America 2012 109 8 3149 3154 10.1073/pnas.1120195109 2-s2.0-84857408957
63. Oliveira M. S., Furian A. F., Rambo L. M., Ribeiro L. R., Royes L. F. F., Ferreira J., Calixto J. B., Mello C. F., Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors. Neuroscience 2008 152 4 1110 1118 10.1016/j.neuroscience.2008.01.005 2-s2.0-41549132023
64. Takemiya T., Matsumura K., Sugiura H., Maehara M., Yasuda S., Uematsu S., Akira S., Yamagata K., Endothelial microsomal prostaglandin E synthase-1 exacerbates neuronal loss induced by kainate. Journal of Neuroscience Research 2010 88 2 381 390 10.1002/jnr.22195 2-s2.0-74049087479
65. Yamagata K., Matsumura K., Inoue W., Shiraki T., Suzuki K., Yasuda S., Sugiura H., Cao C., Watanabe Y., Kobayashi S., Coexpression of microsomal-type prostaglandin E synthase with cyclooxygenase-2 in brain endothelial cells of rats during endotoxin-induced fever. Journal of Neuroscience 2001 21 8 2669 2677 2-s2.0-0035871649
66. Takemiya T., Matsumura K., Sugiura H., Yasuda S., Uematsu S., Akira S., Yamagata K., Endothelial microsomal prostaglandin e synthase-1 facilitates neurotoxicity by elevating astrocytic Ca2+ levels. Neurochemistry International 2011 58 4 489 496 10.1016/j.neuint.2011.01.003 2-s2.0-79952104975
67. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., Ikeda T., Fueki M., Ueno A., Oh-ishi S., Kudo I., Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. Journal of Biological Chemistry 2000 275 42 32783 32792 2-s2.0-0034692689
68. Ciceri P., Zhang Y., Shaffer A. F., Leahy K. M., Woerner M. B., Smith W. G., Seibert K., Isakson P. C., Pharmacology of celecoxib in rat brain after kainate administration. The Journal of Pharmacology and Experimental Therapeutics 2002 302 3 846 852 10.1124/jpet.302.3.846 2-s2.0-0036720458
69. Salvadori M. G. S. S., Banderõ C. R. R., Jesse A. C., Gomes A. T., Rambo L. M., Bueno L. M., Bortoluzzi V. T., Oliveira M. S., Mello C. F., Prostaglandin E2 potentiates methylmalonate-induced seizures. Epilepsia 2012 53 1 189 198 10.1111/j.1528-1167.2011.03326.x 2-s2.0-84855423270
70. Cimino P. J., Keene C. D., Breyer R. M., Montine K. S., Montine T. J., Therapeutic targets in prostaglandin E2 signaling for neurologic disease. Current Medicinal Chemistry 2008 15 19 1863 1869 10.2174/092986708785132915 2-s2.0-53249131262
71. Carlson N. G., Rojas M. A., Black J. D., Redd J. W., Hille J., Hill K. E., Rose J. W., Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. Journal of Neuroinflammation 2009 6, article 5 10.1186/1742-2094-6-5 2-s2.0-62149105218
72. Walters J. N., Bickford J. S., Newsom K. J., Beachy D. E., Barilovits S. J., Herlihy J., Nick H. S., Regulation of human microsomal prostaglandin E synthase-1 by IL-1 β requires a distal enhancer element with a unique role for C/EBP β Biochemical Journal 2012 443 2 561 571 10.1042/BJ20111801 2-s2.0-84859450254
73. O'Banion M. K., Miller J. C., Chang J. W., Kaplan M. D., Coleman P. D., Interleukin-1 β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. Journal of Neurochemistry 1996 66 6 2532 2540 2-s2.0-0029953089
74. Chen C., Bazan N. G., Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. Journal of Neurophysiology 2005 93 2 929 941 10.1152/jn.00696.2004 2-s2.0-12544250740
75. Takemiya T., Yamagata K., Intercellular signaling pathway among endothelia, astrocytes and neurons in excitatory neuronal damage. International Journal of Molecular Sciences 2013 14 4 8345 8357 10.3390/ijms14048345 2-s2.0-84877052534
76. Vezzani A., Friedman A., Brain inflammation as a biomarker in epilepsy. Biomarkers in Medicine 2011 5 5 607 614 10.2217/bmm.11.61 2-s2.0-80054797400
77. Friedman A., Dingledine R., Molecular cascades that mediate the influence of inflammation on epilepsy. Epilepsia 2011 52 3 33 39 10.1111/j.1528-1167.2011.03034.x 2-s2.0-79955681508
78. Xu D., Miller S. D., Koh S., Immune mechanisms in epileptogenesis. Frontiers in Cellular Neuroscience 2013 7, article 195
79. Weir M. R., Sperling R. S., Reicin A., Gertz B. J., Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program. The American Heart Journal 2003 146 4 591 604 10.1016/S0002-8703(03)00398-3 2-s2.0-0142120428